| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9039 |
| Human Intestinal Absorption | HIA+ | 0.9907 |
| Caco-2 Permeability | Caco2+ | 0.7983 |
| P-glycoprotein Substrate | Non-substrate | 0.7062 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9443 |
| Non-inhibitor | 0.9702 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9178 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9347 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7808 |
| CYP450 2D6 Substrate | Non-substrate | 0.8968 |
| CYP450 3A4 Substrate | Non-substrate | 0.5763 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7990 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8833 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9268 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8458 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9361 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8493 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9756 |
| Non-inhibitor | 0.9417 |
| AMES Toxicity | Non AMES toxic | 0.9292 |
| Carcinogens | Non-carcinogens | 0.7736 |
| Fish Toxicity | High FHMT | 0.9453 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9659 |
| Honey Bee Toxicity | High HBT | 0.7611 |
| Biodegradation | Not ready biodegradable | 0.8886 |
| Acute Oral Toxicity | III | 0.8586 |
| Carcinogenicity (Three-class) | Non-required | 0.5206 |